Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has infected millions, with more than 275,000 fatal cases as of May 8, 2020. Currently, there are no specific COVID-19 therapies. Most patients depend on mechanical ventilation. Current...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cell Rep Med
Prif Awduron: Bonam, Srinivasa Reddy, Kaveri, Srini V., Sakuntabhai, Anavaj, Gilardin, Laurent, Bayry, Jagadeesh
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Elsevier 2020
Pynciau:
Perspective
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7190525/
https://ncbi.nlm.nih.gov/pubmed/32562483
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xcrm.2020.100016
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg